| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 53.69B | 56.47B | 67.54B | 54.43B | 67.68B |
| Gross Profit | 17.58B | 18.09B | 21.49B | 15.45B | 22.79B |
| EBITDA | 6.79B | 5.40B | 9.84B | 8.94B | 16.30B |
| Net Income | 3.49B | 4.27B | 6.71B | 5.03B | 9.65B |
Balance Sheet | |||||
| Total Assets | 74.98B | 76.26B | 78.87B | 75.91B | 55.47B |
| Cash, Cash Equivalents and Short-Term Investments | 33.78B | 34.82B | 33.39B | 26.89B | 16.86B |
| Total Debt | 4.24B | 4.37B | 4.64B | 6.85B | 5.44B |
| Total Liabilities | 13.86B | 15.31B | 19.69B | 21.78B | 20.68B |
| Stockholders Equity | 55.47B | 55.10B | 53.83B | 48.57B | 29.62B |
Cash Flow | |||||
| Free Cash Flow | 4.79B | 6.82B | 13.32B | -6.41B | 6.17B |
| Operating Cash Flow | 6.06B | 7.94B | 15.13B | -3.42B | 8.33B |
| Investing Cash Flow | -3.48B | -454.30M | -4.72B | -3.81B | -2.32B |
| Financing Cash Flow | -3.18B | -4.37B | -4.63B | 15.45B | -3.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.99T | 36.89 | 12.42% | 1.34% | 4.89% | 50.48% | |
68 Neutral | HK$495.52B | ― | -13.46% | ― | 11.91% | -106.71% | |
68 Neutral | HK$39.70B | 28.28 | 20.24% | 3.18% | 13.14% | -19.58% | |
67 Neutral | HK$324.89B | 14.92 | 8.57% | 3.48% | 16.27% | -3.87% | |
62 Neutral | HK$151.63B | 41.95 | 5.69% | 1.81% | -10.42% | -37.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | HK$2.33B | 9.74 | 8.16% | 4.75% | -3.18% | -36.46% |